Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut–microbiota–brain axis

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  Wenwen Zhang,et al.  Effects of dietary phosphatidylcholine and sphingomyelin on DSS-induced colitis by regulating metabolism and gut microbiota in mice. , 2022, The Journal of nutritional biochemistry.

[3]  B. Hinz,et al.  Multipotent stromal cells: One name, multiple identities. , 2021, Cell stem cell.

[4]  K. Hashimoto,et al.  Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson’s disease mice by gut microbiome , 2021, Brain Research Bulletin.

[5]  Y. Guan,et al.  Roles of α-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson's disease progression , 2021, Molecular medicine reports.

[6]  F. Vizoso,et al.  Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives , 2021, International journal of molecular sciences.

[7]  A. Wilber,et al.  Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model , 2021, Theranostics.

[8]  M. Hornberger,et al.  Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota , 2021, Journal of Parkinson's disease.

[9]  Tal Frolinger,et al.  Chronic Stress-Induced Depression and Anxiety Priming Modulated by Gut-Brain-Axis Immunity , 2021, Frontiers in Immunology.

[10]  Yuko Fujita,et al.  Ingestion of Faecalibaculum rodentium causes depression-like phenotypes in resilient Ephx2 knock-out mice: A role of brain-gut-microbiota axis via the subdiaphragmatic vagus nerve. , 2021, Journal of affective disorders.

[11]  Yuko Fujita,et al.  Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice , 2021, Scientific Reports.

[12]  K. Meng,et al.  Metabolomic signatures for liver tissue and cecum contents in high-fat diet-induced obese mice based on UHPLC-Q-TOF/MS , 2021, Nutrition & Metabolism.

[13]  L. Du,et al.  Enhanced Neuroprotective Effects of Epicatechin Gallate Encapsulated by Bovine Milk-Derived Exosomes against Parkinson's Disease through Antiapoptosis and Antimitophagy. , 2021, Journal of agricultural and food chemistry.

[14]  I. Charles,et al.  Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation , 2021, NPJ Parkinson's disease.

[15]  D. Pei,et al.  Challenges and advances in clinical applications of mesenchymal stromal cells , 2021, Journal of Hematology & Oncology.

[16]  K. Hashimoto,et al.  A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes , 2021, Brain, Behavior, and Immunity.

[17]  Keun-A Chang,et al.  Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model , 2020, International journal of molecular sciences.

[18]  C. Jorgensen,et al.  Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation , 2020, Frontiers in Bioengineering and Biotechnology.

[19]  M. Camilleri,et al.  Parkinson disease and the gut: new insights into pathogenesis and clinical relevance , 2020, Nature Reviews Gastroenterology & Hepatology.

[20]  V. de Freitas,et al.  Oral interactions between a green tea flavanol extract and red wine anthocyanin extract using a new cell-based model: insights on the effect of different oral epithelia , 2020, Scientific Reports.

[21]  D. Agić,et al.  An in vitro and in silico evaluation of bioactive potential of cornelian cherry (Cornus mas L.) extracts rich in polyphenols and iridoids. , 2020, Food chemistry.

[22]  K. Cao,et al.  Evaluation of phenolic components (anthocyanins, flavanols, phenolic acids, and flavonols) and their antioxidant properties of peach fruits , 2020, Scientia Horticulturae.

[23]  Yuko Fujita,et al.  Maternal glyphosate exposure causes autism-like behaviors in offspring through increased expression of soluble epoxide hydrolase , 2020, Proceedings of the National Academy of Sciences.

[24]  G. Nowicka,et al.  Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions , 2020, Cancers.

[25]  K. Hashimoto,et al.  Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis. , 2020, Journal of affective disorders.

[26]  S. An,et al.  Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy , 2020, Cell Death & Disease.

[27]  V. Lazar,et al.  A Comprehensive Picture of Extracellular Vesicles and Their Contents. Molecular Transfer to Cancer Cells , 2020, Cancers.

[28]  K. Hashimoto,et al.  Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain , 2019, Aging.

[29]  Nikhil Panicker,et al.  Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease , 2019, Neuron.

[30]  H. Martinson,et al.  Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease , 2019, Front. Neurosci..

[31]  Y. Zhang,et al.  Exosomes: biogenesis, biologic function and clinical potential , 2019, Cell & Bioscience.

[32]  Xue Yang,et al.  Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. , 2019, International immunopharmacology.

[33]  R. Duvoisin,et al.  Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice , 2018, Front. Behav. Neurosci..

[34]  O. Gordeeva,et al.  Tumorigenic and Differentiation Potentials of Embryonic Stem Cells Depend on TGFβ Family Signaling: Lessons from Teratocarcinoma Cells Stimulated to Differentiate with Retinoic Acid , 2017, Stem cells international.

[35]  M. Udayabanu,et al.  Gut microbiota: Implications in Parkinson's disease , 2017, Parkinsonism & Related Disorders.

[36]  M. Matthay,et al.  Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction following Trauma or Sepsis , 2016 .

[37]  H. Malkki.  Parkinson disease: Could gut microbiota influence severity of Parkinson disease? , 2017, Nature Reviews Neurology.

[38]  A. Ascherio,et al.  The epidemiology of Parkinson's disease: risk factors and prevention , 2016, The Lancet Neurology.

[39]  H. Reichmann,et al.  Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors , 2015, Nature Reviews Neurology.

[40]  E. Horváth-Puhó,et al.  Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.

[41]  L. Leal,et al.  Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease , 2015, Evidence-based complementary and alternative medicine : eCAM.

[42]  E. Pekkonen,et al.  Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.

[43]  Jia-Yi Li,et al.  Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats , 2014, Acta Neuropathologica.

[44]  D. Bonamonte,et al.  Fusidic acid in skin infections and infected atopic eczema. , 2014, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[45]  G. Xie,et al.  Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[46]  G. Viana,et al.  Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats , 2013, Pharmacology Biochemistry and Behavior.

[47]  Masayuki Yamamoto,et al.  Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease. , 2013, Antioxidants & redox signaling.

[48]  E. Jones,et al.  Markers for Characterization of Bone Marrow Multipotential Stromal Cells , 2012, Stem cells international.

[49]  K. Shannon,et al.  Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases , 2012, Movement disorders : official journal of the Movement Disorder Society.

[50]  R. Kamble,et al.  Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson's Disease: A Pilot Clinical Study , 2012, Stem cells international.

[51]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[52]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[53]  J. Raber,et al.  Novel object recognition in Apoe −/− mice improved by neonatal implantation of wild-type multipotential stromal cells , 2006, Experimental Neurology.

[54]  K. Hashimoto,et al.  Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress. , 2020, Journal of affective disorders.

[55]  E. Bieberich,et al.  Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research. , 2017, Journal of Alzheimer's disease : JAD.

[56]  A. Raymond,et al.  Stem cell therapy in neurodegenerative diseases , 2012, Neural regeneration research.

[57]  G. Meredith,et al.  MPTP mouse models of Parkinson's disease: an update. , 2011, Journal of Parkinson's disease.